Cargando…
Cytochalasin B Treatment and Osmotic Pressure Enhance the Production of Extracellular Vesicles (EVs) with Improved Drug Loading Capacity
Extracellular vesicles (EVs) have been highlighted as novel drug carriers due to their unique structural properties and intrinsic features, including high stability, biocompatibility, and cell-targeting properties. Although many efforts have been made to harness these features to develop a clinicall...
Autores principales: | Nair, Ashita, Bu, Jiyoon, Rawding, Piper A., Do, Steven C., Li, Hangpeng, Hong, Seungpyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746776/ https://www.ncbi.nlm.nih.gov/pubmed/35009953 http://dx.doi.org/10.3390/nano12010003 |
Ejemplares similares
-
Hierarchically Multivalent Peptide–Nanoparticle Architectures: A Systematic Approach to Engineer Surface Adhesion
por: Jeong, Woo‐jin, et al.
Publicado: (2021) -
Increased Yield of Extracellular Vesicles after Cytochalasin B Treatment and Vortexing
por: Kurbangaleeva, Sirina V., et al.
Publicado: (2023) -
Tri‐modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell‐free DNA using machine learning algorithm
por: Bu, Jiyoon, et al.
Publicado: (2021) -
Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)
por: Lee, Taehee, et al.
Publicado: (2022) -
Potentials and capabilities of the Extracellular Vesicle (EV) Array
por: Jørgensen, Malene Møller, et al.
Publicado: (2015)